ESR2 and prostate cancer: Together, these data identify ERβ as a candidate effector of BPA action in prostate cancer cells expressing the AR-T877A mutant and demonstrate that BPA induces a unique transcriptional signature in prostate cancer cells that may be influenced by AR status.